EXC
BMO hits the brakes
Exelon just got a little less exciting in the eyes of BMO Capital. Analyst James Thalacker downgraded the utility from Outperform to Market Perform and shaved the price target to $49 from $52.
That’s not exactly a cinematic collapse — more like taking the foot off the gas and rolling down to a more neutral lane. But in utility land, where expectations tend to move like a shopping cart with one bad wheel, even a small downgrade can matter.
Why you should care
When a big broker changes its tune, investors tend to listen, especially on a name like Exelon where the thesis often hinges on steady returns, regulated assets, and the occasional surprise from rate cases or policy shifts. A lower target doesn’t mean disaster; it means the upside math just got a little less generous.
The takeaway
For Exelon shareholders, the message is pretty straightforward: the stock still has a case, but BMO isn’t seeing enough juice to keep calling it a clear winner.
Big picture: in utilities, “less bad” can still be a rating change worth watching.